Cargando…
Multiomics and machine learning in lung cancer prognosis
Autores principales: | Gao, Yanan, Zhou, Rui, Lyu, Qingwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475596/ https://www.ncbi.nlm.nih.gov/pubmed/32944369 http://dx.doi.org/10.21037/jtd-2019-itm-013 |
Ejemplares similares
-
Combining immunotherapy and radiotherapy in lung cancer: a promising future?
por: Zhou, Jieling, et al.
Publicado: (2020) -
CAR-T cell therapy for lung cancer: a promising but challenging future
por: Zhong, Shupeng, et al.
Publicado: (2020) -
Innovative approaches to immunotherapy in breast cancer
por: Quinn, Kylie M.
Publicado: (2020) -
Cancer patient stratification based on the tumor microenvironment
por: Ying, Le, et al.
Publicado: (2020) -
Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
por: Chan, Jack D., et al.
Publicado: (2020)